DNA Extractor

Closed Solicitation Posted

Solicitation number
75N95025P00064
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health, is seeking to procure a DNA Extractor, specifically a Maxwell RSC System (part no. AS4500) for the Center for Alzheimer's Disease and Related Dementias. The solicitation is a combined synopsis/request for quotation (RFQ) for a commercial item under simplified acquisition procedures, with a NAICS code of 334516 and a small business size standard of 1,000 employees. Evaluation criteria will prioritize technical capability and past performance, which are considered significantly more important than price, with offerors required to demonstrate their ability to meet the government's requirements for automated nucleic acid purification. All potential vendors must have an active System for Award Management (SAM) registration and submit comprehensive quotes including unit pricing, shipping costs, delivery terms, and product specifications. Responses are due by March 24, 2025, at 12:00 pm Eastern Time, to be submitted electronically to Contract Specialist Andrea Clay.

There is no specific set-aside designation for this procurement, and the solicitation does not mention any incumbent contractors. The government anticipates awarding a firm fixed-price purchase order with a delivery timeline of 30 days after order receipt, to be delivered to 9000 Rockville Pike, Bethesda, MD 20892. While the exact award value is not specified, the procurement is not expected to exceed the simplified acquisition threshold. The solicitation requires the DNA extractor to have capabilities for processing 1-16 samples per run and integrating with a liquid handler, with the specific requirement being a Promega DNA Extractor or an equivalent product. Vendors proposing an equal product must provide detailed documentation demonstrating that their offering meets the salient physical, functional, and performance characteristics specified in the purchase description. Additional requirements include providing a Dun & Bradstreet Number, Taxpayer Identification Number, and certification of business size.

Notice text

Title:     DNA Extractor

(i)    This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.

(ii)    The solicitation number is 75N95025Q00064 and the solicitation is issued as a request for quotation (RFQ).
    
This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures;  and FAR Part 12—Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.


(iii)    The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2025-03, with effective date January 17, 2025.

(iv)    The associated NAICS code 334516 and the small business size standard is 1000 employees.  

(v)    This requirement is for the following: Promega DNA Extractor (or equal). See Purchase Description attached

     
(vi)     The Government anticipates award of a firm fixed-price purchase order for this     acquisition, and the anticipated delivery date is 30 days after receipt of order.
The place of delivery and acceptance will be 9000 Rockville Pike, Bethesda, MD 20892.


(vii)    The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses:  https://www.acquisition.gov/browse/index/far   https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html   

(End of provision)

The following provisions apply to this acquisition and are incorporated by reference:
• FAR 52.204-7, System for Award Management (Nov 2024)
• FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020)
• FAR 52.211-6, Brand Name or Equal (Aug 1999)
• FAR 52.212-1, Instructions to Offerors-Commercial Items (Sep 2023)
• FAR 52.212-3, Offeror Representations and Certifications-Commercial Items (May 2024)
• FAR 52.225-2, Buy American Certificate (Oct 2022)
• HHSAR 352.239-73, Electronic and Information Technology Accessibility Notice (Dec 2015)

The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses:
https://www.acquisition.gov/browse/index/far     https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html  
https://www.acquisition.gov/caac-letters 


(End of clause)

The following clauses apply to this acquisition and are incorporated by reference:
• FAR 52.204-13, System for Award Management Maintenance (Oct 2018)
• FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020)
• FAR 52.212-4, Contract Terms and Conditions-Commercial Items (Nov 2023). Addendum to this FAR clause applies to this acquisition and is attached.

The following provisions and clauses apply to this acquisition and are attached in full text.  Offerors MUST complete the provisions at 52.204-24 and 52.204-26 and submit completed copies as separate documents with their proposal.

• FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021)
• FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (Oct 2020)
• FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items (Jan 2025) (DEVIATION Feb 2025) Per CAAC Letters 2025-01 and 2025-02, FAR 52.222-21, Prohibition of Segregated Facilities and FAR 52.222-26 - Equal Opportunity will not be considered when making award decisions or enforce requirements.
• HHSAR 352.239-78, Information and Communication Technology Accessibility Notice (Feb 2024) 
• HHSAR 352.239-79, Information and Communication Technology Accessibility Notice (Feb 2024) (DEVIATION). 

FAR DEVIATION STATEMENT: The CAAC Letter 2025-01-Supplement 1 and CAAC Letter 2025-02-Supplement 1 are applicable to this acquisition.
System updates may lag policy updates. The System for Award Management (SAM) may continue to require entities to complete representations based on provisions that are not included in agency solicitations. Examples include 52.222-25, Affirmative Action Compliance, and paragraph (d) of 52.212-3, Offeror Representations and Certifications—Commercial Products and Commercial Services. Contracting officers will not consider these representations when making award decisions or enforce requirements. Entities are not required to, nor are they able to, update their entity registration to remove these representations in SAM. The mentioned CAAC Letters  may be accessed electronically at this address: CAAC Letters | Acquisition.GOV.


• NIH Invoice and Payment Provisions (Mar 2023)

(viii)    The provision at FAR clause 52.212-2, Evaluation-Commercial Items, applies to this acquisition.

(a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers: (i) technical capability of the item offered to meet the Government requirement; (ii) past performance [see FAR 13.106-2(b)(3)]; (iii) price. Technical and past performance, when combined, are significantly more important than price. 

(b) Options. The Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that an offer is unacceptable if the option prices are significantly unbalanced. Evaluation of options shall not obligate the Government to exercise the option(s).

(c) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.

(ix)    The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items (May 2024), with its offer. If the offeror has completed FAR clause 52.212-3 at www.sam.gov, then the offeror does not need to provide a completed copy with its offer. 

(x)    The clause at FAR 52.212-4, Contract Terms and Conditions-Commercial Items (Nov 2023), applies to this acquisition. Addendum to this FAR clause applies to this acquisition and is attached.

(xii)    There are no additional contract requirement(s) or terms and conditions applicable to this acquisition.  

(xiii)    The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. 

(xiv)    Responses to this solicitation must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. The price quote shall include unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s), product description, and any other information or factors that may be considered in the award decision. Such factors may include past performance, special features required for effective program performance, trade-in considerations, probable life of the product selected as compared with that of a comparable product, warranty considerations, maintenance availability, and environmental and energy efficiency considerations. 


Respondents proposing on an equal product of the brand-name product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the product offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order. 

The Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

All quotations must be received by Monday March 24, 2025 at 12:00 pm Eastern Time and must reference solicitation number 7N95025Q00064.  Responses must be submitted electronically to Andrea Clay, Contract Specialist, at amcgee@nida.nih.gov 

Fax responses will not be accepted.

(xiv)    The name and of the individual to contact for information regarding the solicitation:
Andrea Clay
Contract Specialist
amcgee@nida.nih.gov
 

Files

File Type Posted
FAR_52.212-4 Addendum.pdf PDF
HHSAR 352.239-78 Feb 2024.pdf PDF
FAR 52.212-5 (Jan 2025).pdf PDF
FAR 52.204-26 (Oct 2020).pdf PDF
FAR 52.204-24 (Nov 2021).pdf PDF
Invoicing Instructions.pdf PDF
Purchase Description.pdf PDF
HHSAR 352.239-79 Feb 2024.pdf PDF

Notice history

Notice Type Posted
This notice Latest solicitation Solicitation
DNA Extractor Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
CSS - Upgrading PExA 2.1 to Vial-Based (PExA Cap) NAICS 334516 Office of Logisitics and Acquisition Operations No set-aside
NIA:Non-Competitive Combined Synopsis/Solicitation NAICS 334516 Office of Logisitics and Acquisition Operations No set-aside
Notice of Intent DNA Synthesizer Frederick, Maryland 21702, United States · NAICS 334516 — No set-aside
Synthesis and Distribution of Drugs of Abuse and Related Compounds NAICS 541715 National Institute on Drug Abuse Total Small Business
Combines Synopsis Solicitation- Automated Spatial NAICS 334516 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors